Contract CDMO with 25 global sites for biologics and small-molecule manufacturing
Curia operates a contract development and manufacturing organization spanning discovery through commercialization, with 25 sites and 3,500 employees across the US, UK, Italy, Spain, and India. The hiring and project mix reveal a manufacturing-first operation: two-thirds of active roles are in manufacturing and engineering, with heavy focus on automation reliability, equipment downtime, and CGMP/FDA compliance. Current work centers on process transfer, formulation-specific filling operations, and quality deviation reduction—reflecting both growth scaling (Albuquerque expansion) and operational maturity challenges in regulated pharma.
Notable leadership hires: Site Quality Head
Curia is a Contract Development and Manufacturing Organization with over 30 years of experience. The company provides integrated drug development and manufacturing services across biologics and small molecules, from early discovery through commercial-scale production. Its service portfolio includes discovery biology, pre-formulation, contract manufacturing, formulation, aseptic fill-finish, syringe and vial filling, lyophilization, and clinical/commercial API production. The company operates 25 sites globally and employs 3,500 people, serving pharmaceutical manufacturers seeking outsourced manufacturing capacity with embedded regulatory and analytical expertise.
Curia operates 25 global manufacturing sites across the United States, United Kingdom, Italy, Spain, and India, with 3,500 employees and active expansion in Albuquerque.
Curia provides contract development and manufacturing for biologics and small molecules, including discovery, formulation, aseptic fill-finish, syringe/vial filling, lyophilization, and clinical/commercial API production with integrated regulatory and analytical capabilities.
Other companies in the same industry, closest in size